Phase 1 Single Ascending Dose Study of Intravenous Eravacycline in Volunteers.

Trial Profile

Phase 1 Single Ascending Dose Study of Intravenous Eravacycline in Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2010

At a glance

  • Drugs Eravacycline (Primary)
  • Indications Gram-negative infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Tetraphase Pharmaceuticals
  • Most Recent Events

    • 13 Sep 2010 Results have been presented at 2010 ICAAC, according to a Tetraphase Pharmaceuticals media release.
    • 02 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top